
Admira Pharmaceuticals Private Limited
About Admira Pharmaceuticals Private Limited
Data last updated:
Admira Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the manufacturing segment of the jewellery and fashion accessories sector. It was incorporated on 11 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33309UP2019PTC114525. Its GSTIN is 09AASCA0295N1ZY (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nitin Kumar and Rashmi Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 296 First Floor Near Meerut Road Vikas Nagar, Ghaziabad, Uttar Pradesh, India – 201001.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.99 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.76 Lakh (net margin 8%) and EBITDA of ₹3.71 Lakh (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 165% over three years.
Company details
Contact details
Admira Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No – 296 First Floor Near Meerut Road Vikas Nagar, Ghaziabad, Uttar Pradesh, India – 201001
- IndustryJewelry & Fashion Accessories, Manufacturing, Watches And Clocks
To see the full contact details of Admira Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Admira Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Admira Pharmaceuticals Private Limited, buy the company report.
Financials of Admira Pharmaceuticals Private Limited
FY 2025 filings availableAdmira Pharmaceuticals Private Limited reported revenue of ₹21.99 Lakh (up 189% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 165% over three years, including 189% growth in the latest year. EBITDA rose 657% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.9% | ||||
| Net Profit Margin | 8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Admira Pharmaceuticals Private Limited, buy the company report.
Board of directors of Admira Pharmaceuticals Private Limited
Admira Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Kumar | Director | 11 Mar 2019 | 7 Years 8 Months | Current |
| Rashmi Agarwal | Director | 29 Aug 2025 | 1 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Admira Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admira Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Admira Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA0295N1ZY | Uttar Pradesh | Active | 03 Apr 2019 |
To see the full GST registrations and return filing status of Admira Pharmaceuticals Private Limited, buy the company report.
Recent activity
Admira Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Ankit Agarwal ceased to be Director on 30 Aug 2025.
Frequently asked questions
Admira Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in manufacturing, within the jewelry and fashion accessories industry. It was incorporated on 11 March 2019 (7+ years old) and is registered under CIN U33309UP2019PTC114525.
Admira Pharmaceuticals has 2 current directors:
- Nitin Kumar - Director
- Rashmi Agarwal - Director
The latest financial statements of Admira Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Admira Pharmaceuticals is 09AASCA0295N1ZY, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Admira Pharmaceuticals is U33309UP2019PTC114525. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admira Pharmaceuticals was incorporated on 11 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
Ankit Agarwal ceased to be Director on 30 Aug 2025. Rashmi Agarwal was appointed as Director on 29 Aug 2025. Ankit Agarwal was appointed as Director on 14 Mar 2024. Admira Pharmaceuticals has 5 board changes on record in total.
The registered office of Admira Pharmaceuticals is at Plot No – 296 First Floor Near Meerut Road Vikas Nagar, Ghaziabad, Uttar Pradesh, India – 201001.
Admira Pharmaceuticals operates in the jewelry and fashion accessories industry, in the manufacturing segment.
Admira Pharmaceuticals can be reached at its registered office: Plot No – 296 First Floor Near Meerut Road Vikas Nagar, Ghaziabad, Uttar Pradesh, India – 201001.

